LORATADINE TABLETS

The Defense Logistics Agency has awarded a single-unit delivery order, SPE2DP26F7487, to DMS PHARMACEUTICAL GROUP INC under the base contract SPE2DX25D9900 for one pill of LORATADINE TABLETS identified by NSN 6505013770448 at a fixed price of $20.01. The contract is a firm fixed price transaction with no option quantities or variance allowed, and performance is limited to a single delivery scheduled for July 29, 2026, to Fort Stewart, Georgia, at the bulk break point W33RBS. Shipment must be sent via traceable means and parcel post is strictly prohibited, with FOB Destination terms placing title and risk of loss on the contractor until delivery is completed at the destination. The contractor, identified by CAGE code 1UNB0, is responsible for delivering the product to the designated location where government personnel will inspect and accept the item. Packaging and marking requirements mandate inclusion of the NSN, contractor CAGE codes 1LEZO and 3KJG9, the NDC numbers 00904-7511-61 and 51079-0246-20, the transaction control number W33RBS53220238, and the handling instruction SHIP BY TRACEABLE MEANS. Invoicing must be submitted electronically through Wide Area WorkFlow in compliance with DFARS 252.232-7003 and will be processed by the Defense Finance and Accounting Service in Columbus, Ohio. Payment details are tied to the AAC/TAS/ACRN BX: 97X4930 5CBX 001 2620 S33189. The procurement is managed under NAICS code 424210 for pharmaceutical and biological product merchant wholesalers, with no socioeconomic certifications or size status disclosed. No specific contractual clauses, quality standards beyond conformity to contract requirements, MIL-STD references, bar-coding specifications, or inspection criteria beyond governmental acceptance at destination are detailed. Contract administration is overseen by Lisa Quinn as the contracting officer and Shairy M. Cartagena as the administrative POC, though no Contracting Officer’s Representative or technical representative is specified. The award reflects a highly specific, low-value pharmaceutical supply transaction conducted under